FDA Investigator Marcelo O Mangalindan, Jr

Marcelo O Mangalindan, Jr has conducted inspections on 194 sites in 17 countries as of 21 May 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
194
Last Inspection Date:
21 May 2018
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, South Africa, Korea (Republic of), France, Australia, Poland, Hungary, Canada, Germany, Taiwan, Spain, United Kingdom of Great Britain and Northern Ireland, Italy, Belgium, Slovakia, Netherlands, Argentina
FDA Investigators that have inspected at least one site in common with Marcelo O Mangalindan, Jr:
Addam S Reynolds, Adetutu M Gidado, Albert A Salvador, Albert M Brindle, Allen Lou, Althea A Williams, Amy L Singer, Amy M Codella, Amy M Cramer, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Andrew A Hoopes, Andria L Kuhlman, Anita R Michael, Ann Marie Montemurro, Annemarie Bodnar, Anthony M Criscuolo, Jr, Antoinette L Ravelli, Asia D Clark, Astrida B Mattson, Atul J Agrawal, Audrey Thereset Uy, Barbara D Wright, Barbara J Maulfair, Barbara Jwilimczyk Macri, Ben Du, Bing Lin, Brandon L Mariner, Brandy N Lepage, Brenda L Reihing, Brenda S Zimmer, PhD, Brian D Young, Brian S Keefer, Byungja E Marciante, Carl A Anderson, Carol A Perry, Carol A Robles, Cary Greene, Catherine J Laufmann, Charles A Snipes, PhD, Charles I Ann, Charles J Chacko, Ching Jeyg Chang, Christian D Lynch (CDL), Christina K Theodorou, Christina N Maurino, Christina Theodorou, Christopher Bastedo, Christopher J Hurst, Craig D Zagata, Craig W Swanson, Crystal A Harlan, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Cynthia White, Daniel J Grabicki, Daniel T Lee, Darin S Wiegers, David A Oluwo, David H Smith, David J Hafner, Dawn L Wydner, Deborah J Parris, Debra J Bennett, Debra L Pagano, Dena M Elimam, Denise M Digiulio, Denise M Visco, Investigator, Derek S Dealy, Dessa A Antoine, Devon Jenkins, Dhaval H Patel, Dolores Harper, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edward D Mcdonald, Edward O'shaughnessy, Emest F Bizjak, Emily A Baldwin, Emmanuel Jramos Maldonado, Eric Rothschild, Erika M Wilkerson, Erin D Mccaffery, Erin M Mcdowell, Frank J Marciniak, Frederick F Razzaghi, Gabrielle J Swain, Gayle S Lawson, George Pyramides, Gianine E Delade, Gianine E Tompkins, Gillian B Nardelli, Gobiga Vanniyasingam, Guerlain Ulysse, Hala L Selby, Helen B Ricalde, Hitesh R Patel, Hyojong Kwon, PhD, Iqra Iftikhar, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James M Mason, James P Mcevoy, Jason M Sluzynski, Jay B Shah, Jean Blackston Hill, Jean M Kelahan, Jeen S Min, Jennifer A Bazergui, Jennifer Macmillan, Jessica M Monteiro, Jill M Sooter, Jo Annc Declement, Joan A Loreng, Jogy George, Jonathan T Little, Jonee J Mearns, Jose M Cayuela, Jose Ohernandez Guzman, Joseph F Mcginnis, RPh, Joseph L Despins, PhD, Joseph T Dougherty, Joy Rkozlowski Klena, Juanita P Versace, Judith A Jones, Judith A Paterson, Julianne C Mccullough, Justine Tomasso, K Gonzlez, Kara A Scheibner, PhD, Karen A Briggs, Karen E D'orazio, Karen F Tomaziefski, Karen M Ferguson, Keith A Schwartz, Keith M Reilly, Kelly Doremus, Kelly I Anderson, Kelly N Kerr, Kendra L Brooks, Kerry A Kurdilla, Kinh Q Mac, Ko U Min, Kris K Moore, Kristen D Evans, Kristen E Rescigno, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Krystal O Ogunremi, Krystyna M Kitson, Kurt A Brorson, PhD, Kyle D Covill, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Lenahan Lenahan, Peter R, Liatte Kreuger, PharmD, Linda M Hoover, Linda R Kuchenthal, Lisa Harlan, Lisa Mathew, Loretta Nemchik, LT Colin E Tack, BSE, LTJG Bradley E Benasutti, Manhar R Patel, Margaret M Sands, Maria Estrella, Marjorie D Schultz, Martha Sullivan Myrick, Matthew R Noonan, Matthew S Mccollough, Mayar M Mussa, Melissa A Freeman, Melissa B Libby, Melissa M Schafer, Meredith L Sheridan, Meyer J Slobotsky, Michael D Omeara, Michael F Skelly, PhD, Michael J Nerz, Michael L Casner, Michael R Klapal, Michael Rosner, Michael Serrano, Michael Skelly, Mike M Rashti, Mindy M Chou, Morris Paul, Msdap Gonzlezk, Murthy Vkn Sikha, Nancy F Scheraga, Nancy M Espinal, Natasha Gupta, Nerizza B Dalena, Nerizza B Guerin, Nicholas A Violand, Nikisha M Bolden, Nina Yang, Patricia S Smith, Paul L Bellamy, Paula J Bretz, Peter R Lenahan, Prabhu P Raju, Ramanda C Gregory, Raymond L Cheung, Regina T Brown, Remache, Richard D Manney, Robert G Ruff, Robert J Maffei, Robert Sharpnack, Robert W Calais, Robert W Mccullough, Rochelle L Cross, Rose Ljean Mary, Russell J Glapion, Ruth A Oni, Sam Chan, Sam Pepe, Sandra Kershaw, Sarah Forney, Schultz, Seng Ching Hwang, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Sinai I Davis, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen J Mottola, Steven E Kane, Steven L Carter, Subramanian Muthukkumar, PhD, Susan M Jackson, Susan T Hadman, Tahseen Mirza, Tamil Arasu, PhD, Tammy L Chavis, Tania E Vizcaino, Tara G Bizjak, Teigan M Mule, Terri L Dodds, Thai D Truong, Thomas E Friel, Thomas N Adjabeng, Thomas R Withers, Tressa T Lewis, Tyanna N Hadley, Unnee Ranjan, Valerie C Reed, Vlada Matusovsky, Wayne E Seifert, Wayne J Meyer, Wayne T Smith, William J Muszynski, William W Dotts, Yangmin Ning, Yiyue Zhang (nmi), PhD, Yong Wu, PhD, Yvesna C Blaise, Yvins Dezan

Marcelo O Mangalindan, Jr's Documents

Publish Date Document Type Title
July, 2015 EIR Hossein Borghaei, D.O. - EIR, 2015-07-30
April, 2011 FDA 483 EDDA Technology, Inc. - Form 483, 2011-04-11
August, 2002 FDA 483 Ethicon, Inc. - Form 483, 2002-08-08
July, 2015 FDA 483 Response Hossein Borghaei, D.O. - Form 483R, 2015-08-21
November, 2017 FDA 483 Janssen Research & Development, LLC - Form 483, 2017-11-21
March, 2016 FDA 483 GlaxoSmithKline LLC - Form 483, 2016-03-18
August, 2013 EIR GlaxoSmithKline LLC - EIR, 2013-08-23
March, 2004 EIR Jane L. Rohlf, MD - EIR, 2004-03-02
February, 2003 FDA 483 Electric Mobility Corp - Form 483, 2003-02-11
March, 2017 EIR Charu Aggarwal, MD, MPH, Hematology-Oncology Division - EIR, 2017-03-28
April, 2016 FDA 483 Merck Sharp & Dohme Corp. - Form 483, 2016-04-12
March, 2014 FDA 483 PACKAGING COORDINATORS LLC - Form 483, 2014-03-14
September, 2017 FDA 483 Joel D. Cooper, M.D. - Form 483, 2017-09-27
June, 2005 EIR Bristol-Meyers Squibb - EIR, 2005-06-03
September, 2014 FDA 483 Tomasz Szczepanski, Dept of Ped Hem, and Onc - Form 483, 2014-09-11
February, 2005 FDA 483 Convatec Inc. - Form 483, 2005-02-08
April, 2017 FDA 483 Stephan A. Grupp, M.D., Ph.D. - Form 483, 2017-04-13
April, 2017 FDA 483 Response Stephan A. Grupp, M.D., Ph.D. - Form 483R, 2017-04-28
February, 2003 EIR Electric Mobility Corp - EIR, 2003-02-11
June, 2016 FDA 483 Teva Branded Pharmaceutical Products R&D - Form 483, 2016-06-30
November, 2014 FDA 483 Marcela V. Maus, M.D. - Form 483, 2014-11-17
May, 2005 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2005-05-06
September, 2015 FDA 483 Digestive Care, Inc. - Form 483, 2015-09-25
June, 2014 EIR Lawrence C. Parish, MD - EIR, 2014-06-09
April, 2016 EIR Merck Sharp & Dohme Corp. - EIR, 2016-04-12
June, 2014 FDA 483 GlaxoSmithKline LLC - Form 483, 2014-06-03
August, 2002 EIR Ethicon, Inc. - EIR, 2002-08-08
March, 2018 FDA 483 Giacomina Massaro-Giordano M.D. - Form 483, 2018-03-09
July, 2015 FDA 483 Hossein Borghaei, D.O. - Form 483, 2015-07-30
September, 2013 FDA 483 Merck & Co., Inc. - Form 483, 2013-09-27
November, 2017 EIR Janssen Research & Development, LLC - EIR, 2017-11-21
September, 2016 EIR Merck & Co Inc - EIR, 2016-09-20
November, 2014 EIR Noelle V. Frey, M.D. - EIR, 2014-11-12
April, 2015 FDA 483 Polysciences, Inc. - Form 483, 2015-04-29
June, 2015 EIR Thomas Jefferson University IRB - EIR, 2015-06-18
December, 2013 FDA 483 Merck Sharp & Dohme Corp. - Form 483, 2013-12-20
April, 2017 EIR Stephan A. Grupp, M.D., Ph.D. - EIR, 2017-04-13
November, 2014 FDA 483 Noelle V. Frey, M.D. - Form 483, 2014-11-12
December, 2013 EIR Merck Sharp & Dohme Corp. - EIR, 2013-12-20
December, 2003 EIR Dvorin, Donald Dr. - EIR, 2003-12-23
November, 2014 EIR Gregory L. Beatty M.D., PhD - EIR, 2014-11-06
January, 2016 EIR Jonathan Rome, MD - EIR, 2016-01-05
June, 2015 FDA 483 Response Thomas Jefferson University IRB - Form 483R, 2015-07-08
June, 2016 FDA 483 Response Teva Branded Pharmaceutical Products R&D - Form 483R, 2016-07-20
July, 2016 FDA 483 Laurie Mereu, MD - Form 483, 2016-07-22
June, 2015 FDA 483 Thomas Jefferson University IRB - Form 483, 2015-06-18
December, 2003 EIR Sanofi-Aventis U.S. LLC - EIR, 2003-12-08
July, 2010 FDA 483 Dr. Javier Cortes - Form 483, 2010-07-30
September, 2013 EIR Merck & Co., Inc. - EIR, 2013-09-27
September, 2013 FDA 483 Response Merck & Co., Inc. - Form 483R, 2013-10-18
May, 2011 FDA 483 Yung-Jue Bang M.D.,Ph.D. Seoul National University Hospital - Form 483, 2011-05-27
November, 2014 FDA 483 Gregory L. Beatty M.D., PhD - Form 483, 2014-11-06
July, 2016 FDA 483 Marta Benavent - Form 483, 2016-07-15
March, 2017 FDA 483 Charu Aggarwal, MD, MPH, Hematology-Oncology Division - Form 483, 2017-03-28
September, 2016 FDA 483 Merck & Co Inc - Form 483, 2016-09-20
June, 2016 EIR Teva Branded Pharmaceutical Products R&D - EIR, 2016-06-30
September, 2016 FDA 483 Response Merck & Co Inc - Form 483R, 2016-10-10
November, 2014 EIR Marcela V. Maus, M.D. - EIR, 2014-11-17
March, 2016 EIR GlaxoSmithKline LLC - EIR, 2016-05-03
December, 2003 FDA 483 Dvorin, Donald Dr. - Form 483, 2003-12-23
June, 2014 EIR GlaxoSmithKline LLC - EIR, 2014-06-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more